View Author
scopus: 6603758046

Vlijmen, B.J.M. van

(Bart van Vlijmen)


patient restenosi factor polymorphism leiden plasminogen activator inhibitor study level 2012-08-03 | id factor v leiden 1000521777 | ip center diabetes inhibitor genotype thromb plasminogen activator allele stent smoker leiden university 4 g variant department association cardiology university procoagulant polymorphisms haemost table plasma follow-up heart percutaneou netherland system stent placement protein c analysis variant mechanism protein sample sepsis expression formation frequency activation acid substitution regression angioplasty procedure 2012-08-03 monraat non-smokers smoking intervention vessel wall insulin carrier 506gln multicenter follow-up study downloaded genotyping gene expression 5 g allele sequence-specific oligonucleotide probes right 130.115.200.143 genotype distributions haemostatic system permission risk factors 11053 t /g thrombosis effect homozygote tissue procoagulant distribution




1 Most Recent Publications

The influence of established genetic variation in the haemostatic system on clinical restenosis after percutaneous coronary interventions (Article)
Pons, D. Monraats, P.S. Winter, R.J. de Tio, R.A. Frants, R.R. Laarse, A. van der Wall, E.E. van der Jukema, J.W. Maat, M.P.M. de Pires, N.M.M. Quax, P.H.A. Vlijmen, B.J.M. van Rosendaal, F.R. Zwinderman, A.H. Doevendans, P.A. Waltenberger, J.
2007-12-01